《习近平经济文选》第一卷中多篇文章对科技创新作出深刻论述。《深化对中长期经济社会发展重大问 题的认识》指出，"实现高质量发展，必须实现依靠创新驱动的内涵型增长"。《中国式现代化要靠科技 现代化作支撑》强调，"必须充分认识科技的战略先导地位和根本支撑作用，锚定二〇三五年建成科技 强国的战略目标，加强顶层设计和统筹谋划，加快实现高水平科技自立自强"。这些重要论述为推动我 国科技事业发展、加快实现高水平科技自立自强提供了科学指引。 纵观世界主要大国兴衰史，科技是其中最重要、最根本的推动力和变量之一。筑牢国家科学技术基础和 提高自主创新能力是大国发展的必然规律。实现高水平科技自立自强是我国应对重大风险挑战和维护国 家战略利益的迫切要求，更是进一步抢抓战略机遇期下好先手棋和赢得新优势的战略选择。要抓住关键 环节，加快推进高水平科技自立自强，把国家和民族发展放在自己力量的基点上。 完善党中央对科技工作集中统一领导的体制，凝聚推动科技创新的强大合力。中国共产党领导是中国特 色科技创新事业不断前进的根本政治保证。加强党对科技事业的领导，关键要把党的领导政治优势充分 发挥出来。应该看到，我国在形成符合国情、满足国家战略需求、自 ...

"河南是我的家乡，我希望家乡能有更多学生到西湖大学，接触顶尖的科学家，脱颖而出，成为改变世 界的力量。"5月15日，河南省驻马店高级中学大讲堂里座无虚席，西湖大学校长、中国科学院院士施一 公回到家乡驻马店，为西湖大学2025年本科招生政策作专场宣讲。 今年，在浙江省"创新班"招生试点的基础上，该校本科招生新增三省两市，其中包括河南省。这是西湖 大学自2022年启动本科教育以来，首次走出浙江开展跨省招生。 西湖大学将通过普通高考面向河南招收本科生，今年招生计划拟为20人（以河南省教育考试院公布计划 为准），涵盖数学与应用数学、物理学、化学、生物科学、材料科学与工程、电子信息工程、人工智 能、临床医学等8个前沿专业。考生选考科目方面，西湖大学要求物理、化学均须选考。 5月16日，深圳理工大学在郑州举行2025年河南省本科招生宣讲会。深圳理工大学校长樊建平向河南考 生发出邀约："河南生源品学兼优，深圳理工大学期待与河南这片充满活力的土地深度交融。" 根据政策，今年深圳理工大学招生对象是选考物理和化学组合的高中毕业生，录取批次为本科普通批。 招生专业如何？在豫招生均按"计算机科学与技术"大类进行录取，所有学生大一不分 ...

Summary of Avantor Conference Call Company Overview - **Company**: Avantor - **Industry**: Life Sciences Tools and Diagnostics Key Points Financial Performance - First quarter results were slightly below investor expectations, but the company remains confident in its platform's strength and resilience [3][4] - The lab solutions segment serves over 300,000 customers globally, with a strong bioprocessing franchise and medical-grade silicone formulations [3][4] - Strong margin execution and best-in-class free cash flow conversion were noted, with earnings aligning with plans and targets [3][4] Leadership Transition - CEO Michael Stubblefield announced a transition after over eleven years of leadership, during which revenue grew from $400 million to $7 billion [5][6] - The board is actively searching for a successor, focusing on candidates with a growth mindset and innovation background [8][9] Tariff Impact and Mitigation Strategies - Avantor's exposure to tariffs from China is estimated at approximately $30 million, with potential EPS impact of 3 to 4 cents if unmitigated [11][12][18] - The company has not incorporated tariff headwinds into its earnings guidance, confident in its ability to offset these through various strategies [12][16] - Mitigation strategies include transparent communication with customers about alternative products and flexible pricing frameworks [13][14] Market Guidance - The updated fiscal year 2025 guidance indicates organic sales decline of negative 1% to positive 1%, reflecting market conditions and policy changes impacting NIH funding [23][24] - The bioscience segment is expected to recover from first-quarter weaknesses, with a strong order book supporting future growth [29][30] Competitive Landscape - The macro environment has created a more competitive landscape, with opportunities for Avantor to gain market share despite challenges [37][39] - The company is focusing on retaining existing accounts and pursuing new business aggressively [4][39] Cost Actions and Margin Outlook - Avantor has expanded its cost savings plan to $400 million by the end of 2027, with significant contributions from procurement and operational efficiencies [46][48] - Long-term EBITDA margin target remains above 20%, although current market conditions may lead to a revised exit rate of around 18% for the year [49][50] Customer Segments and Market Dynamics - Approximately 5% of Avantor's revenue is linked to US academic and government sectors, which have faced funding cuts and spending freezes [41][42] - The company has observed stability in order rates since initial declines in early 2023, with expectations of no further deterioration [43][45] Conclusion - Avantor's leadership emphasizes the company's resilience and strategic positioning in the life sciences market, with ongoing efforts to drive growth and productivity despite macroeconomic challenges [52][53]